ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board: RGRX) (“the Company” or “RegeneRx”). In response to questions received related to this morning’s press release, RegeneRx wishes to publicly clarify certain points and information contained within the release.
